Perrigo Company PLC

PRGO
Real-time BATS EXCHANGE - 02/19 04:00:00 pm
48.205USD
+1.19%
Prev.48.9500
Open49.0700
High49.6700
Low48.7400
Volume1 019 273
Financials
Sales 2018 4 716 M
EBIT 2018 904 M
R. net 2018 131 M
Debt 2018 2 721 M
Rend. 2018 1,46%
P/E ratio 2018 29,97
P/E ratio 2019 17,48
EV / Sales 2018 1,99x
EV / Sales 2019 1,87x
Capitalization 6 650 M
Company
Perrigo Company PLC (Perrigo), formerly Perrigo Company Limited, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company's segments include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx) and Specialty Sciences....
Sector :
Pharmaceuticals - NEC
Calendar :
2019-02-27 Earnings Release
Trading Rating :
Investor Rating :
Latest news
02/14PERRIGO : Announces Patent Litigation Settlement for the Generic Version of Jublia Topical Solution 10%
AQ
02/13PERRIGO : Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
PU
02/11PERRIGO : Statement of changes in beneficial ownership of securities
PU
02/07PERRIGO : Announces FDA Final Approval for its AB Rated Generic Version of Zovirax Cream 5%
AQ
02/05LEAD PLAINTIFF DEADLINE ALERT : Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Perrigo Company plc To Contact The Firm
PR
01/30LEAD PLAINTIFF DEADLINE ALERT : Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Perrigo Company plc To Contact The Firm
BU
01/25LEAD PLAINTIFF DEADLINE ALERT : Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Perrigo Company plc To Contact The Firm
BU
01/23Einhorn's Greenlight sells some positions, covers prominent shorts
RE
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBearishBearish
Resistance50,352,756,0
Spread/Res.-1,4%-5,9%-12%
Spread/Supp.6,5%36%34%
Support46,536,537,0